Article Information
vol. 124 no. 17, 3029-3037
- Accepted May 10, 2011
- Published online August 30, 2011.
Author Information
- Tobias Deuse1,2,3,
- Martina Seifert4,
- Neil Phillips5,
- Andrew Fire6,
- Dolly Tyan6,
- Mark Kay5,
- Philip S. Tsao7,
- Xiaoqin Hua2,3,
- Joachim Velden8,
- Thomas Eiermann9,
- Hans-Dieter Volk4,
- Hermann Reichenspurner2,3,
- Robert C. Robbins1 and
- Sonja Schrepfer1,2,3,*
- 1Cardiothoracic Surgery, Stanford University, Stanford, CA 94305, USA
- 2Cardiovascular Surgery, TSI-laboratory, University Hospital Hamburg, Hamburg 20246, Germany
- 3Cardiovascular Research Center, University Hospital Hamburg, Hamburg 20246, Germany
- 4Institute of Medical Immunology and Berlin-Brandenburg Center for Regenerative Therapies (BCRT) Charité Campus Virchow-Klinikum, Berlin 13353, Germany
- 5Pediatrics, Human Gene Therapy, Stanford University, Stanford, CA 94305, USA
- 6Pathology, Stanford University, Stanford, CA 94305, USA
- 7Cardiovascular Medicine, Stanford University, Stanford, CA 94305, USA
- 8Pathology, University Hospital Hamburg, Hamburg 20246, Germany
- 9Transfusion Medicine, University Hospital Hamburg, Hamburg 20246, Germany
- ↵* Author for correspondence (schrepfer{at}stanford.edu)
Article usage
Usage statistics are calculated at the beginning of each month for the previous month.
Statistics from Altmetric.com
Article navigation
Related articles
Cited by...
More in this TOC section
Similar articles
Other journals from The Company of Biologists
2020 at The Company of Biologists
Despite the challenges of 2020, we were able to bring a number of long-term projects and new ventures to fruition. While we look forward to a new year, join us as we reflect on the triumphs of the last 12 months.
Mole – The Corona Files
"This is not going to go away, 'like a miracle.' We have to do magic. And I know we can."
Mole continues to offer his wise words to researchers on how to manage during the COVID-19 pandemic.
Cell scientist to watch – Christine Faulkner
In an interview, Christine Faulkner talks about where her interest in plant science began, how she found the transition between Australia and the UK, and shares her thoughts on virtual conferences.
Read & Publish participation extends worldwide
“The clear advantages are rapid and efficient exposure and easy access to my article around the world. I believe it is great to have this publishing option in fast-growing fields in biomedical research.”
Dr Jaceques Behmoaras (Imperial College London) shares his experience of publishing Open Access as part of our growing Read & Publish initiative. We now have over 60 institutions in 12 countries taking part – find out more and view our full list of participating institutions.
JCS and COVID-19
For more information on measures Journal of Cell Science is taking to support the community during the COVID-19 pandemic, please see here.
If you have any questions or concerns, please do not hestiate to contact the Editorial Office.